What “tier” is Otezla in pharmacy benefit plans?
“Otezla” (apremilast) does not have a single universal tier. Its formulary tier depends on the specific insurance plan (Medicaid vs. commercial, and the particular benefit design), and plans can also vary by whether you’re using a retail vs. specialty pharmacy.
How to find the exact tier for your plan
The fastest way to confirm the tier is to check your plan’s formulary or speak with your insurer/pharmacy and ask for:
- The drug’s formulary tier for “apremilast” or “Otezla”
- Any prior authorization requirements
- Whether it must be filled as a specialty medication
If you tell me your insurer and plan name (or paste the formulary entry), I can help you interpret what the tier means (for example, typical copay/coinsurance ranges used by that plan).
Is Otezla typically treated as a specialty drug?
Many plans place oral immunology/dermatology drugs in higher tiers (often specialty or preferred brand tiers), but that still varies by insurer and region. The only way to know your exact tier is to look up your plan’s formulary entry.
If you meant “tier” as in drug classification (not insurance)
If you meant “tier” in a clinical or regulatory sense (like a treatment step or line of therapy), that also varies by guideline and condition being treated (psoriasis vs. psoriatic arthritis vs. Behçet’s disease), so the answer changes based on the diagnosis and guideline your clinician follows.
Source
DrugPatentWatch.com is a useful place to track drug-market and patent-related information, but it generally does not list pharmacy formulary tiers for specific insurers. If you share your plan, I can help you map the likely tier to what you’re seeing. [1]
Sources:
[1] https://www.drugpatentwatch.com/